Cellular and molecular interactions between immune system and bone.
Functional interdependence between immune and bone systems is reflected in a number of regulatory molecules acting on the cells of both systems and common precursors for bone and immune cells. Therefore, the disturbances of the immune system may affect bone metabolism, and vice versa. This review addresses the roles of two major immune cell populations, T and B lymphocytes, in the regulation of bone metabolism. Experimental models and human diseases demonstrated that T lymphocytes may produce many bone cell regulatory cytokines, including two essential stimulators of osteoclastogenesis: receptor for activation of nuclear factor kappa b (NF-kappa B) (RANK) ligand (RANKL) and macrophage colony-stimulating factor. The effect of T lymphocytes on osteoclastogenesis may be both stimulatory and inhibitory, and depends on the activation stage and pattern of cytokine production. We showed that acute removal of T lymphocytes stimulated osteoclast differentiation in vitro and enhanced new cartilage and bone formation at non-osseous sites in vivo. B lymphocytes may be even more closely related to bone cells, as B lymphopoiesis requires an intimate contact with osteoblastic/stromal cells, and estrogens, powerful regulators of bone mass, are also involved in the differentiation of the B lymphocyte lineage. Also, B lymphocyte progenitors may give rise to functional osteoclasts. Both B and T lymphocytes may act through the RANKL/RANK/osteoprotegerin cytokine system, which has been independently discovered within immune and bone systems. These cytokines have crucial roles in the development and function of osteoclasts, dendritic cells, and T and B lymphocytes, as well as in the thymus and lymph node organogenesis. The cytokines produced by immune cells may affect bone cell function and vice versa, but the full complexity of these interactions awaits further investigation.
Grcević
D
D
Department of Physiology, Zagreb University School of Medicine, Salata 3b, 10000 Zagreb, Croatia. dgrcevic@mef.hr
Katavić
V
V
Lukić
I K
IK
Kovacić
N
N
Lorenzo
J A
JA
Marusić
A
A
D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology / Q000502:physiology*; D001846:Bone Development / Q000502:physiology; D001847:Bone Diseases / Q000276:immunology / Q000503:physiopathology; D001853:Bone Marrow / Q000502:physiology; D001842:Bone and Bones / Q000378:metabolism*; D002454:Cell Differentiation; D016207:Cytokines / Q000502:physiology; D006801:Humans; D016328:NF-kappa B / Q000502:physiology; D010010:Osteoclasts / Q000502:physiology; D010012:Osteogenesis / Q000502:physiology*; D010014:Osteolysis / Q000503:physiopathology; D013601:T-Lymphocytes / Q000276:immunology / Q000502:physiology*
D016207:Cytokines; D016328:NF-kappa B